Pilot Study of A-FABP Levels as a Predictive Factor of SPECT Results in Asymptomatic Relatives of Patients with Cardiovascular Disease

References

• De Backer G , AmbrosionieE, Borch-JohnsenKet al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). www.escardio.org/guidelines-surveys/esc-guidelines/GuidelinesDocuments/guidelines-CVD-prevention.pdf.14.7.2012
   Google Scholar
• Writing Committee Members; ACC/AHA Task Force Members. 2010 ACCF/AHA Guidelines for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis imaging and preventive, Society of Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Cardiovascular Magnetic Resonance. J. Am. Coll. Cardiol. 56, 2182 – 2199 (2010).
   Google Scholar
• Shaw LJ , RaggiP, CallisterTQ, BermanDS. Prognostic value of coronary artery calcium screening in asymptomatic smokers and non smokers.Eur. Heart J.27, 968 – 975 (2006).
   PubMed Web of Science ®Google Scholar
• Hoff JA , DaviglusML, ChomkaEV, KrainikAJ, SevrukovA, KondosGT. Conventional coronary artery disease risk factors and coronary artery calcium detected by electron beam tomography in 30,908 healthy individuals.Ann. Epidemiol.13, 163 – 169 (2003).
   PubMed Web of Science ®Google Scholar
• Taylor AJ , BindemanJ, FeuersteinI, CaoF, BrazaitisM, O'MalleyPD. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors.J. Am. Coll. Cardiol.46, 807 – 814 (2005).
   PubMed Web of Science ®Google Scholar
• Perrone-Filardi P , AchenbachS, MohlenkampSet al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. Eur. Heart J. 32, 1986 – 1993 (2011).
   PubMed Web of Science ®Google Scholar
• Storch J , CorsicoB. The emerging functions and mechanisms of mammalian fatty acid-binding proteins.Annu. Rev. Nutr.28, 73 – 95 (2008).
   PubMed Web of Science ®Google Scholar
• Tuncman G , ErbayE, HomXet al. A functional genetic variant at the fatty acid binding protein, aP2, locus reduces the risk for hypertriglyceridemia, Type 2 diabetes and cardiovascular disease. Proc. Natl Acad. Sci. USA 103, 6970 – 6975 (2005).
   Web of Science ®Google Scholar
• Tso AWK , XuA, ShamPCet al. Serum adipocyte fatty acid-binding protein as a new biomarker predicting the development of Type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30 (10), 2667 – 2672 (2007).
   PubMed Web of Science ®Google Scholar
• Erbay E , CaoH, HotamisligilGS. Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome.Curr. Atheroscler. Rep.9 (3), 222 – 229 (2007).
   PubMedGoogle Scholar
• Hsu BG , ChenYC, LeeRP, LeeCC, LeeCJ, WangJH. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease.Circ. J.74 (2), 327 – 331 (2010).
   PubMed Web of Science ®Google Scholar
• Makowski L , BoordJB, MaedaKet al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 7, 699 – 705 (2001).
   PubMed Web of Science ®Google Scholar
• Miyoshi T , OnoueG, HirohataAet al. Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 211 (1), 164 – 169 (2010).
   PubMed Web of Science ®Google Scholar
• Rhee EJ , LeeWY, ParkCYet al. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur. J. Endocrinol. 160 (2), 165 – 172 (2009).
   PubMed Web of Science ®Google Scholar
• Krusinova E , PelikanovaT. Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?Diabetes Res. Clin. Pract.82 (Suppl. 2), 127 – 134 (2008).
   PubMedGoogle Scholar
• Makowski L , BrittinghamKC, ReynoldsJM, SuttlesJ, HotamisligilGS. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities.J. Biol. Chem.280, 12888 – 12895 (2005).
   PubMed Web of Science ®Google Scholar
• Peeters W , de KleijnDPV, VinkAet al. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. Eur. Heart J. 32, 1758 – 1768 (2011).
   PubMed Web of Science ®Google Scholar
• Doi M , MiyoshiT, HirohataSet al. Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men. Cardiovasc. Diabetol. 10, 44 (2011).
   PubMed Web of Science ®Google Scholar
• Bagheri R , QuasimAN, MehtaNNet al. Relation of plasma fatty acid bindings proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with Type 2 diabetes mellitus. Am. J. Cardiol. 106 (8), 1118 – 1123 (2010).
   PubMed Web of Science ®Google Scholar
• Agatston AS , JanowitzWR, HildnerFJ, ZusmerNR, ViamonteM, DetranoR. Quantification of coronary artery calcium using ultrafast computed tomography.J. Am. Coll. Cardiol.15, 827 – 832 (1990).
   PubMed Web of Science ®Google Scholar
• The R Project for Statistical Computing. www.r-project.org
   Google Scholar
• Kral BG , BeckerLC, VaidyaD, YanekLR, BeckerDM. Silent myocardial ischaemia and long term coronary artery disease outcomes in apparently healthy people from families with early-onset ischaemic heart disease.Eur. Heart J.32, 2766 – 2772 (2011).
   PubMed Web of Science ®Google Scholar
• Khandaker MH , MillerTD, ChareonthaitaweeP, AskewJW, HodgeDO, GibbonsRJ. Stress single photon emission computed tomography for detection of coronary artery disease and risk stratification of asymptomatic patients at moderate risk.J. Nucl. Cardiol.16, 516 – 523 (2009).
   PubMed Web of Science ®Google Scholar
• Zellweger MJ , HachamovitchR, KangXet al. Threshold, incidence, and predictors of prognostically high risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease. J. Nucl. Cardiol. 16, 193 – 200 (2009).
   PubMed Web of Science ®Google Scholar
• Chang SM , NabiF, XuJet al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J. Am. Coll. Cardiol. 54, 1872 – 1882 (2009).
   PubMed Web of Science ®Google Scholar
• Blumenthal RS , BeckerDM, YanekLRet al. Comparison of coronary calcium and stress myocardial perfusion imaging in apparently healthy siblings of individuals with premature coronary artery disease. Am. J. Cardiol. 97, 328 – 333 (2006).
   PubMed Web of Science ®Google Scholar
• Rozanski A , GransarH, ShawLet al. Comparison of the atherosclerotic burden among asymptomatic patients vs matched volunteers. J. Nucl. Cardiol. 18, 291 – 298 (2011).
   PubMed Web of Science ®Google Scholar
• Sovová E , VrbkováJ, KaletováMet al. Is there dependence between the level of AFABP and calcium score in asymptomatic relatives of patients with cardiovascular diseases? Vnitr. Lek. 59, 31 – 36 (2013).
   PubMedGoogle Scholar
• Metelková I , KamínekM, SovováEet al. Risk stratification by cardiac gated SPECT combined with coronary artery calcium score in patients with diabetes mellitus and/or renal failure. Vnitr. Lek. 6 (11), 1122 – 1129 (2010).
   Google Scholar
• Huang CL , WuYW, WuCCet al. Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary disease. Cardiovasc. Diabetol. 12, 105 (2013).
   PubMed Web of Science ®Google Scholar
• Karpisek M , StejskalD, KotolovaHet al. Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidemia. Eur. J. Clin. Invest. 37, 637 – 642 (2007).
   PubMed Web of Science ®Google Scholar
• Sovova E , KaletovaM, StejskalDet al. Intervention for cardiovascular risk factors decreases adipocyte fatty acid binding protein levels in males – a pilot study. Central Eur. J. Med. 9 (1), 28 – 33 (2014).
   Google Scholar